Phathom Pharmaceuticals (PHAT) Interest Coverage Ratio (2018 - 2026)
Phathom Pharmaceuticals (PHAT) reported Interest Coverage Ratio of 0.98 for Q1 2026, up 77.55% year-over-year from 0.55 in Q1 2025, and down 171.36% quarter-over-quarter from 0.36 in Q4 2025.
Phathom Pharmaceuticals (PHAT) Interest Coverage Ratio (2018 - 2026) Analysis & Trends
Phathom Pharmaceuticals (PHAT) has 9 years of Interest Coverage Ratio data on file, last reported at 0.98 in Q1 2026.
- Interest Coverage Ratio for Q1 2026 came in at 0.98, up 77.55% year-over-year; the trailing twelve-month figure through Mar 2026 was 1.47 (up 62.65% YoY), and the FY2025 annual result was 2.35, up 39.04% from the prior year.
- Interest Coverage Ratio fell to 0.98 in Q1 2026 per PHAT's latest filing, from 0.36 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 0.36 in Q4 2025 and troughed at 13.74 in Q1 2022.
- A 5-year average of 4.24 and a median of 3.83 in 2024 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2024 and 2025: Interest Coverage Ratio tumbled 31.98% in 2024, then soared 88.7% in 2025.
- A 5-year view of Interest Coverage Ratio shows it stood at 4.86 in 2022, then declined by 10.41% to 5.36 in 2023, then jumped by 40.41% to 3.2 in 2024, then soared by 88.7% to 0.36 in 2025, then tumbled by 171.36% to 0.98 in 2026.
- Business Quant data shows PHAT's Interest Coverage Ratio at 0.98 in Q1 2026, 0.36 in Q4 2025, and 0.95 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Phathom Pharmaceuticals | 895.99 Mn | 712.23 Mn | 46.31 Mn | -0.98 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.98 |
| Dec 31, 2025 | -0.36 |
| Sep 30, 2025 | -0.95 |
| Jun 30, 2025 | -3.42 |
| Mar 31, 2025 | -4.36 |
| Dec 31, 2024 | -3.20 |
| Sep 30, 2024 | -3.83 |
| Jun 30, 2024 | -4.35 |
| Mar 31, 2024 | -4.07 |
| Dec 31, 2023 | -5.36 |
| Sep 30, 2023 | -3.53 |
| Jun 30, 2023 | -3.30 |
| Mar 31, 2023 | -3.26 |
| Dec 31, 2022 | -4.86 |
| Sep 30, 2022 | -4.58 |
| Jun 30, 2022 | -8.00 |
| Mar 31, 2022 | -13.74 |
| Dec 31, 2021 | -11.91 |
| Sep 30, 2021 | -22.31 |
| Jun 30, 2021 | -28.12 |